Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm

  1. Barrio, S.
  2. Gallardo, M.
  3. Arenas, A.
  4. Ayala, R.
  5. Rapado, I.
  6. Rueda, D.
  7. Jimenez, A.
  8. Albizua, E.
  9. Burgaleta, C.
  10. Gilsanz, F.
  11. Martinez-Lopez, J.
Aldizkaria:
British Journal of Haematology

ISSN: 0007-1048 1365-2141

Argitalpen urtea: 2013

Alea: 161

Zenbakia: 5

Orrialdeak: 667-676

Mota: Artikulua

DOI: 10.1111/BJH.12308 GOOGLE SCHOLAR